Ian T. Clark

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ John G. Saia, as attorney-in-fact for Ian T. Clark
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian T. Clark:

Form 4 holding Director

GoodRx Holdings, Inc.

Security class
Restricted Stock Unit
Shares / value
51,745
Estimated value
$405,681
Report date
08 Jul 2024
Price
$7.84
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

Guardant Health, Inc.

Security class
Common Stock
Shares / value
2,975
Estimated value
$318,029
Report date
20 May 2026
Price
$106.90
Ownership
By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account
Form 4 holding Director

Guardant Health, Inc.

Security class
Restricted Stock Units
Shares / value
5,092
Estimated value
$225,413
Report date
18 Jun 2025
Price
$27.87
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

AVROBIO, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
17,643
Estimated value
Report date
06 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

AGIOS PHARMACEUTICALS, INC.

Security class
Restricted stock unit
Shares / value
0
Estimated value
Report date
20 May 2022
Price
$24.79
Ownership
Direct
Underlying class
Common stock
Underlying amount

Insider Reports Filed by Ian T. Clark

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .